LIVN earnings date and last-quarter result: last quarter beat, P/E 39.73. Updated 2026-07-23.
LivaNova (LIVN) Research Hub
LivaNova (LIVN) trades on NASDAQ, GB in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 80.62 USD (-0.35%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 39.73, market cap 4.31B. This hub links to the full technical, earnings and options research available for LIVN.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, GB |
| Last close | 80.62 USD (-0.35%) |
| 52-week range | 74.11 USD – 85.76 USD |
| Trend regime | Range |
| 14-day RSI | 70.6 (Overbought) |
| Trailing P/E | 39.73 |
| Market cap | 4.31B |
| Dividend yield | 0.00% |
Available research for LIVN
Covered Call on LIVN: how it works, illustrative setup around the real 80.62 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on LIVN: how it works, illustrative setup around the real 80.62 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on LIVN: how it works, illustrative setup around the real 80.62 USD price, max profit/loss, breakeven and when to use it. Educational.
LIVN technical analysis: range, last 80.62 USD, RSI 70.6, 52w range 74.11 USD–85.76 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is LIVN in?
LivaNova (LIVN) is classified under Healthcare (Medical - Devices), listed on NASDAQ, GB.
Is LIVN in an uptrend or downtrend?
As of 2026-10-26, LIVN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is LIVN's trailing P/E ratio?
LIVN's trailing P/E is 39.73, with a market cap of 4.31B. See the earnings research page for full valuation detail.